Brief: Waldencast Announces Sale Of Obagi Medical To Bridgepoint
01/06/2026 12:15
BRIEF-Waldencast Announces Sale Of Obagi Medical To Bridgepoint June 1 (Reuters) - Waldencast PLC WALD.O:
WALDENCAST ANNOUNCES SALE OF OBAGI MEDICAL TO BRIDGEPOINT
WALDENCAST - DEAL VALUED AT UP TO $460 MILLION
WALDENCAST - COMPANY TO REPAY ABOUT $178 MILLION SENIOR SECURED TERM LOAN AT COMPLETION
WALDENCAST - APPOINTS FELIPE DUTRA AS EXECUTIVE CHAIRMAN EFFECTIVE IMMEDIATELY
Source text: ID:nGNX4Wb4nh
Further company coverage: WALD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Waldencast
See all newsBrief: Waldencast PLC Files Form 15 To Deregister Its Securities And Suspend Its SEC Reporting Obligations Under The Exchange Act
Brief: Waldencast PLC Files Form 25 To Voluntary Delist From Nasdaq And Deregister Its Securities Under The Exchange Act
Brief: Waldencast Announces Sale Of Obagi Medical To Bridgepoint
Brief: Waldencast Announces Conclusion Of SEC Investigation
UK’s Waldencast posts flat Q4 revenue on Milk Makeup weakness, withholds outlook